Preparation of 1-(4-hydroxy-iminomethylpyridinium)-3-pyridiniumpropane dibromide is described. This compound represents a new acetylcholinesterase (AChE) reactivator, which has no substituents on the second pyridinium ring as found in other commonly used AChE reactivators. The reactivation ability of this reactivator was tested on tabun- and cyclosarin-inhibited AChE. According to the results obtained, the new compound (without substitution and with decreased molecule size) showed increased reactivation potency in case of cyclosarin inhibited AChE. A potent oxime for treatment of tabun and cyclosarin-caused intoxications was thus obtained via slight modification of the reactivator structure (compared to trimedoxime and K027).

Center of Advanced Studies Faculty of Military Health Sciences Hradec Kralove Czech Republic

Zobrazit více v PubMed

Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004;38:151–216. PubMed

Tu A.T. Chemical Terrorism: Horrors in Tokyo Subway and Matsumoto City. Alaken Inc.; Fort Collins, CO: 2002.

Matousek J. Health and environmental threats associated with the destruction of chemical weapons. Ann. N. Y. Acad. Sci. 2006;1076:549–558. PubMed

Poziomek E.J., Hackley B.E., Steinberg G.M. J. Pyridinium aldoximes. J. Org. Chem. 1958;23:714–717.

Lüttringhaus A., Hagedorn I. Quaternary hydroxyiminomethylpyridinium salts. The dischloride of bis-(4-hydroxyiminomethyl-1-pyridinium-methyl)-ether (Lueh6), a new reactivator of acetylcholinesterase inhibited by organic phosphoric acid esters. Arzneimittelforschung. 1964;14:1–5. PubMed

Hagedorn I., Gündel W.H., Schoene K. Reactivation of phosphorylated acetylcholine esterase with oximes: contribution to the study of the reaction course. Arzneimittelforschung. 1969;19:603–606. PubMed

Krejcova G., Kuca K., Sevelova L. Cyclosarin-An Organophosphate Nerve Agent. Def. Sci. J. 2005;55:105–115.

Musilek K., Kuca K., Jun D., Dolezal M. Progress in synthesis of new acetylcholinesterase reactivators in period 1990-2004. Curr. Org. Chem. 2007;11:229–238.

Musilek K., Lipka L., Racakova V., Kuca K., Jun D., Dohnal V., Dolezal M. New methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chem. Pap. 2006;60:48–51. doi: 10.2478/s11696-006-0008-x. DOI

Eyer P., Szinicz L., Thiermann H., Worek F., Zilker T. Testing of antidotes for organophosphorus compounds: Experimental procedures and clinical reality. Toxicology. 2007;233:108–119. PubMed

Kuca K., Cabal J., Musilek K., Jun D., Bajgar J. Effective bisquaternary reactivators of tabun-inhibited AChE. J. Appl. Toxicol. 2005;25:491–495. PubMed

Szinicz L., Worek F., Thiermann H., Kehe K., Eckert S., Eyer P. Development of antidotes: Problems and strategies. Toxicology. 2007;233:23–30. PubMed

Yang G.Y., Yoon J.H., Seong C.M., Park N.S., Jung Y.S. Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull. Korean Chem. Soc. 2003;24:1368–1370. doi: 10.5012/bkcs.2003.24.9.1368. DOI

Park N.-J., Jung Y.-S., Musilek K., Jun D., Kuca K. Potency of several structurally different acetylcholinesterase reactivators to reactivate house fly and bovine acetylcholinesterases inhibited by paraoxon and DFP. B. Korean Chem. Soc. 2006;27:1401–1404. doi: 10.5012/bkcs.2006.27.9.1401. DOI

Chennamaneni S.R., Vobalaboina V., Garlapati A. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity. Bioorg. Med. Chem. Lett. 2005;15:3076–3080. doi: 10.1016/j.bmcl.2005.04.026. PubMed DOI

Srinivas Rao C., Venkateswarlu V., Achaiah G. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes. Part 2: synthesis and biological activity. Bioorg. Med. Chem. Lett. 2006;16:2134–2138. PubMed

Musilek K., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J. Enzym. Inhib. Med. Chem. 2005;20:409–415. doi: 10.1080/14756360500179762. PubMed DOI

Musilek K., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2006;16:622–627. doi: 10.1016/j.bmcl.2005.10.059. PubMed DOI

Musilek K., Holas O., Kuca K., Jun D., Dohnal V., Dolezal M. Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2006;16:5673–5676. doi: 10.1016/j.bmcl.2006.08.011. PubMed DOI

Musilek K., Holas O., Kuca K., Jun D., Dohnal V., Opletalova V., Dolezal M. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene Linker – Synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 2007;17:3172–3176. PubMed

Oh K.A., Yang G.Y., Jun D., Kuca K., Jung Y.S. Bis-pyridiumaldoxime reactivators connected with CH2O(CH2)n OCH2 linkers between pyridinium rings and their reactivity against VX. Biorg. Med. Chem. Lett. 2006;16:4852. doi: 10.1016/j.bmcl.2006.06.063. PubMed DOI

Odzak R., Calic M., Hrenar T., Primozic I., Kovarik Z. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase. Toxicology. 2007;233:85–96. doi: 10.1016/j.tox.2006.08.003. PubMed DOI

Kuca K., Bielavsky J., Cabal J., Bielavska M. Synthesis of a potential reactivator of acetylcholinesterase-1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 2003;44:3123–3125.

Kuca K., Kassa J. In vitro reactivation of acetylcholinesterase using the oxime K027. Vet. Hum. Toxicol. 2004;46:15–18. PubMed

Calic M., Lucic Vrdoljak A., Radic B., Jelic D., Jun D., Kuca K., Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology. 2006;219:85–96. PubMed

Lucic-Vrdoljak A., Calic M., Radic B., Berend S., Kuca K., Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology. 2006;228:41–50. PubMed

Kassa J., Kuca K., Cabal J., Paar M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J. Toxicol. Environ. Health A. 2006;69:1875–1882. PubMed

Kuca K., Cabal J., Jun D., Bajgar J., Hrabinova M. Potency of new structurally different oximes to reactivate cyclosarin inhibited-human brain acetylcholinesterases. J. Enzyme Inhib. Med. Chem. 2006;21:6636–666. doi: 10.1080/14756360600850916. PubMed DOI

Musilek K., Kuca K., Jun D., Dolezal M. Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Lett. Org. Chem. 2006;3:831–835. PubMed

Kuca K., Cabal J. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent. Toxicol. Mech. Meth. 2005;15:247–252. PubMed

Bajgar J., Fusek J., Kuca K., Bartosova L., Jun D. Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction. Mini-Rev. Med. Chem. 2007;7:461–466. PubMed

Kuca K., Jun D., Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini-Rev. Med. Chem. 2006;6:269–277. PubMed

Kuca K., Jun D., Musilek K., Bajgar J. Reactivators of tabun-Inhibited tcetylcholinesterase: Structure biological activity relationship. Front. Drug Des. Discov. 2007;3:381–394.

Ekstrom F., Akfur C., Tunemalm A.K., Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry. 2006;45:74–81. PubMed

Ekstrom F., Pang Y.P., Boman M., Artursson E., Akfur C., Borjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol. 2006;72:597–607. PubMed

Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats